CARLA MORGAN-GIBBS

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology AUGUSTA, GA NPI 1124072129

General Payments — all program years on this page

$3,558.15

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 224
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $327.81 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $301.1116
Education $26.702

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $101.475
Astellas Pharma US Inc $66.764
Organon LLC $39.152
MILLICENT US INC $26.702
Biogen, Inc. $26.351
Lilly USA, LLC $19.151
ABBVIE INC. $16.711
Sumitomo Pharma America, Inc. $16.431
Agile Therapeutics, Inc. $15.091

By program year

Program yearAmountRecords
2018 $894.8168
2019 $629.6144
2020 $256.0318
2021 $438.3222
2022 $737.0641
2023 $274.5113
2024 $327.8118

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096931072 Novo Nordisk Inc $20.96 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097536591 Novo Nordisk Inc $23.80 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097614683 Novo Nordisk Inc $18.41 11/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097663044 Novo Nordisk Inc $24.55 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097704424 Novo Nordisk Inc $13.75 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104868454 Biogen, Inc. $26.35 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105066186 ABBVIE INC. $16.71 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136084856 Lilly USA, LLC $19.15 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136206571 Organon Llc $19.68 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136206573 Organon Llc $19.47 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139339648 Astellas Pharma US Inc $14.44 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139355191 Astellas Pharma US Inc $16.56 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139371251 Astellas Pharma US Inc $20.92 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139446442 Astellas Pharma US Inc $14.84 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148893501 Sumitomo Pharma America, Inc. $16.43 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150910172 MILLICENT US INC $13.35 11/05/2024 Education Undisputed 01/23/2026 View at CMS
1150910174 MILLICENT US INC $13.35 12/09/2024 Education Undisputed 01/23/2026 View at CMS
1154842013 Agile Therapeutics, Inc. $15.09 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.